Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S (NOVO B)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on NOVO NORDISK A/S
05/25NOVO NORDISK A/S : Patent Issued for Liraglutide in Cardiovascular Conditions (U..
AQ
05/25REPORTS SUMMARIZE TYPE 2 DIABETES FI : a...
AQ
05/25NOVO NORDISK A/S : Team Novo Nordisk Joins the United Nations in Celebration of ..
AQ
05/25NOVO NORDISK A/S : Real-World Evidence Shows Clinically Meaningful Weight Loss i..
AQ
05/25NOVO NORDISK A/S : - Real-world evidence shows clinically meaningful weight loss..
AQ
05/25NOVO NORDISK A/S : licenses kidney disease drug from Epigen
AQ
05/24NOVO NORDISK A/S : Real-world evidence shows clinically meaningful weight loss i..
PU
05/22BIOPSY NEEDLES MARKET 2018 : Future Development, Global Industry Insight and For..
AQ
05/22NOVO NORDISK A/S : - Share repurchase programme
AQ
05/22NOVO NORDISK A/S : NovoEight(R) Maintains Potency When Stored at 40 Degree C Off..
AQ
05/22NOVO NORDISK A/S : Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Fa..
AQ
05/21NOVO NORDISK A/S : NovoEight® maintains potency when stored at 40ºC offering peo..
AQ
05/18NOVO NORDISK A/S : - Share repurchase programme
AQ
05/18NOVO NORDISK A/S : expands type 1 diabetes R&D
AQ
05/18NOVO NORDISK A/S : Citing significant progress on a cure for diabetes, Novo Nord..
AQ
05/17NOVO NORDISK A/S : Researchers at Novo Nordisk Have Reported New Data on Crohn's..
AQ
05/17NOVO NORDISK A/S : INDYCAR Driver Charlie Kimball and Novo Nordisk unveil new No..
AQ
05/17NOVO NORDISK A/S : Collaboration between Lund University researchers and Novo No..
AQ
05/17NOVO NORDISK A/S : BioLamina and Novo Nordisk Partner to Advance Stem Cell Based..
AQ
05/16NOVO NORDISK A/S : increases commitment to stem cell-based therapies
AQ
05/15NOVO NORDISK A/S : Trenton Schools Celebrate 650,000 Minutes of Physical Activit..
AQ
05/15NOVO NORDISK A/S : - Trading in shares by board members, executives and associat..
AQ
05/14NOVO NORDISK A/S : - Share repurchase programme
AQ
05/14NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/14NOVO NORDISK A/S : Trenton Schools Celebrate 650,000 Minutes of Physical Activit..
AQ
05/10NOVO NORDISK A/S : Patent Issued for MIC-1 Fusion Proteins and Uses (USPTO 99562..
AQ
05/10NOVO NORDISK A/S : Reports Summarize Proinsulin Study Results from Novo Nordisk ..
AQ
05/10DISCOVERY : Novo Nordisk and Discovery Education Announce 'Super Health, Super Y..
AQ
05/09NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/09NOVO NORDISK A/S : - Share repurchase programme
AQ
05/09NOVO NORDISK A/S : purchases B shares worth DKK 1,038 million from Novo Holdings..
AQ
05/09NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/08NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/08NOVO NORDISK A/S : Trading in Novo Nordisk Shares By Board Members, Executives, ..
AQ
05/08NOVO NORDISK A/S : operating profit decreased by 8% in Danish kroner and increas..
AQ
05/07NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/04NOVO NORDISK A/S : purchases B shares worth DKK 1,038 million from Novo Holdings..
AQ
05/04NOVO NORDISK A/S : Trading in Novo Nordisk Shares by Board Members, Executives, ..
AQ
05/04NOVO NORDISK A/S : fends off Lillys GLP-1 challenge in Q1
AQ
05/04NOVO NORDISK A/S : participates in new research project Hypo-RESOLVE to investig..
AQ
05/04NOVO NORDISK A/S : - Share repurchase programme
AQ
05/04GLOBAL BENZALKONIUM CHLORIDE MARKET : 9strategy.biz added a depth and professio..
AQ
05/04NOVO NORDISK A/S : Share buyback
CO
05/03NOVO NORDISK A/S : Studies from Novo Nordisk Reveal New Findings on Chronic Kidn..
AQ
05/03NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
AQ
05/02NOVO NORDISK A/S : Participates in New Research Project Hypo-RESOLVE to Investig..
AQ
05/02ELI LILLY AND : Drugmaker Novo Nordisk beats first quarter profit expectations, ..
RE
05/02NOVO NORDISK A/S : 1Q Beat Expectations; Cautions on Competition, Pricing
DJ
05/02NOVO NORDISK A/S : operating profit decreased by 8% in Danish kroner and increas..
GL
05/02NOVO NORDISK A/S : 1st quarter results
CO
05/01NOVO NORDISK A/S : - Share repurchase programme
AQ
05/01NOVO NORDISK A/S : participates in new research project Hypo-RESOLVE to investig..
AQ
05/01NOVO NORDISK A/S : Share buyback
CO
04/30NOVO NORDISK A/S : Monthly statement on outstanding equity shares and voting rig..
CO
04/28NOVO NORDISK A/S : With Growth Comes Opportunity - $1.3 Million Johnston County ..
AQ
04/27EMISPHERE TECHNOLOGIES : Amends License Agreement with Novo Nordisk
AQ
04/27NOVO NORDISK A/S : Tackling diabetes over the long term
AQ
04/27NOVO NORDISK A/S : - Reduction of the share capital
AQ
04/26NOVO NORDISK A/S : Sempre Health and Novo Nordisk Partner to Improve Medication ..
AQ
04/26BP names former Statoil boss Lund as next chairman
RE
04/26BP Appoints New Chairman to Start January 2019
DJ
04/25NOVO NORDISK A/S : - Reduction of Share Capital
AQ
04/25NOVO NORDISK A/S : Activity Works Expands In Philadelphia, Newark (NJ) and Trent..
AQ
04/24Women's Health Market Analysis on Segment, Trend, Growth, Volume, Size, Globa..
AQ
04/24NOVO NORDISK A/S : - Reduction of the share capital
GL
04/24NOVO NORDISK A/S : - Reduction of the share capital
AQ
04/23NOVO NORDISK A/S : Share repurchase programme
AQ
04/23NOVO NORDISK A/S : - Red Cross and announce ground-breaking partnership to tackl..
AQ
04/23Tackling diabetes over long term
AQ
04/23Tackling diabetes over long term
AQ
04/23Tackling diabetes over long term
AQ
04/23NOVO NORDISK A/S : Share buyback
CO
04/21NOVO NORDISK A/S : commits nearly $7 million for Minglin Ma`s diabetes research
AQ
04/21NOVO NORDISK A/S : and Red Cross to tackle NCDs in humanitarian crises
AQ
04/21NOVO NORDISK A/S : Sempre Health and Novo Nordisk to partner to lower diabetes d..
AQ
1  2  3  4  5  6  7  8  9  10Next
Financials ( DKK)
Sales 2018 111 B
EBIT 2018 47 097 M
Net income 2018 38 880 M
Finance 2018 15 545 M
Yield 2018 2,63%
P/E ratio 2018 19,04
P/E ratio 2019 18,45
EV / Sales 2018 5,13x
EV / Sales 2019 4,87x
Capitalization 583 B
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 328  DKK
Spread / Average Target 7,6%
EPS Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Helge Lund Chairman
Maziar Mike Doustdar Executive Vice President-International Operations
Karsten Munk Knudsen Chief Financial Officer
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-8.94%91 116
JOHNSON & JOHNSON-11.45%325 801
PFIZER-0.91%208 713
NOVARTIS-8.30%194 397
ROCHE HOLDING LTD.-9.17%189 708
MERCK AND COMPANY5.01%158 970